vs
Sezzle Inc.（SEZL）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Sezzle Inc.的季度营收约是再鼎医药的1.1倍（$135.5M vs $127.1M），Sezzle Inc.同比增速更快（29.2% vs 17.1%），过去两年Sezzle Inc.的营收复合增速更高（111.9% vs 20.8%）
Sezzle是一家总部位于美国明尼阿波利斯的上市金融科技企业，业务覆盖美国与加拿大。公司主打先享后付支付平台，为合作线上商家的消费者提供零息分期支付解决方案。截至2021年6月，平台注册用户超1000万，合作商户数量超4.8万家。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
SEZL vs ZLAB — 直观对比
营收规模更大
SEZL
是对方的1.1倍
$127.1M
营收增速更快
SEZL
高出12.1%
17.1%
两年增速更快
SEZL
近两年复合增速
20.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $135.5M | $127.1M |
| 净利润 | $51.3M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 50.9% | -54.6% |
| 净利率 | 37.9% | — |
| 营收同比 | 29.2% | 17.1% |
| 净利润同比 | 41.9% | — |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SEZLZLAB
| Q1 26 | $135.5M | — | ||
| Q4 25 | $78.2M | $127.1M | ||
| Q3 25 | $57.5M | $115.4M | ||
| Q2 25 | $52.0M | $109.1M | ||
| Q1 25 | $48.2M | $105.7M | ||
| Q4 24 | $48.4M | $108.5M | ||
| Q3 24 | $35.6M | $101.8M | ||
| Q2 24 | $30.2M | $100.1M |
净利润SEZLZLAB
| Q1 26 | $51.3M | — | ||
| Q4 25 | $42.7M | — | ||
| Q3 25 | $26.7M | $-36.0M | ||
| Q2 25 | $27.6M | $-40.7M | ||
| Q1 25 | $36.2M | $-48.4M | ||
| Q4 24 | $25.4M | — | ||
| Q3 24 | $15.4M | $-41.7M | ||
| Q2 24 | $29.7M | $-80.3M |
毛利率SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% |
营业利润率SEZLZLAB
| Q1 26 | 50.9% | — | ||
| Q4 25 | 70.6% | -54.6% | ||
| Q3 25 | 61.9% | -42.3% | ||
| Q2 25 | 69.4% | -50.3% | ||
| Q1 25 | — | -53.3% | ||
| Q4 24 | 63.8% | -62.6% | ||
| Q3 24 | 58.6% | -66.6% | ||
| Q2 24 | 55.3% | -76.0% |
净利率SEZLZLAB
| Q1 26 | 37.9% | — | ||
| Q4 25 | 54.6% | — | ||
| Q3 25 | 46.4% | -31.2% | ||
| Q2 25 | 53.1% | -37.3% | ||
| Q1 25 | 75.1% | -45.8% | ||
| Q4 24 | 52.4% | — | ||
| Q3 24 | 43.4% | -40.9% | ||
| Q2 24 | 98.4% | -80.2% |
每股收益（稀释后）SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | $1.19 | $-0.05 | ||
| Q3 25 | $0.75 | $-0.03 | ||
| Q2 25 | $0.78 | $-0.04 | ||
| Q1 25 | $1.00 | $-0.04 | ||
| Q4 24 | $0.71 | $-0.09 | ||
| Q3 24 | $0.44 | $-0.04 | ||
| Q2 24 | $0.82 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $196.7M | $715.5M |
| 总资产 | $454.3M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | $64.1M | $689.6M | ||
| Q3 25 | $104.1M | $717.2M | ||
| Q2 25 | $88.9M | $732.2M | ||
| Q1 25 | $88.9M | $757.3M | ||
| Q4 24 | $73.2M | $779.7M | ||
| Q3 24 | $80.1M | $616.1M | ||
| Q2 24 | $58.0M | $630.0M |
股东权益SEZLZLAB
| Q1 26 | $196.7M | — | ||
| Q4 25 | $169.8M | $715.5M | ||
| Q3 25 | $155.3M | $759.9M | ||
| Q2 25 | $130.4M | $791.7M | ||
| Q1 25 | $125.8M | $810.8M | ||
| Q4 24 | $87.8M | $840.9M | ||
| Q3 24 | $61.1M | $667.7M | ||
| Q2 24 | $50.3M | $704.2M |
总资产SEZLZLAB
| Q1 26 | $454.3M | — | ||
| Q4 25 | $400.2M | $1.2B | ||
| Q3 25 | $367.0M | $1.2B | ||
| Q2 25 | $350.6M | $1.2B | ||
| Q1 25 | $298.1M | $1.2B | ||
| Q4 24 | $298.4M | $1.2B | ||
| Q3 24 | $252.9M | $985.3M | ||
| Q2 24 | $212.1M | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | $70.6M | $-26.0M | ||
| Q3 25 | $63.7M | $-32.0M | ||
| Q2 25 | $23.1M | $-31.0M | ||
| Q1 25 | $52.5M | $-61.7M | ||
| Q4 24 | $57.4M | $-55.8M | ||
| Q3 24 | $35.1M | $-26.8M | ||
| Q2 24 | $22.2M | $-42.2M |
自由现金流SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | $70.6M | $-26.7M | ||
| Q3 25 | $63.6M | $-35.0M | ||
| Q2 25 | $22.7M | $-33.9M | ||
| Q1 25 | $52.5M | $-63.2M | ||
| Q4 24 | $57.4M | $-58.4M | ||
| Q3 24 | $35.1M | $-28.2M | ||
| Q2 24 | $22.2M | $-42.9M |
自由现金流率SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | 90.2% | -21.0% | ||
| Q3 25 | 110.6% | -30.4% | ||
| Q2 25 | 43.6% | -31.1% | ||
| Q1 25 | 108.9% | -59.9% | ||
| Q4 24 | 118.5% | -53.8% | ||
| Q3 24 | 98.6% | -27.7% | ||
| Q2 24 | 73.4% | -42.9% |
资本支出强度SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.8% | 2.6% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.1% | 0.7% |
现金转化率SEZLZLAB
| Q1 26 | — | — | ||
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.39× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 2.26× | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | 0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SEZL
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
